Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker ...

Pfizer enters the obesity drug market with its Metsera acquisition, aiming to challenge leaders Eli Lilly and Novo Nordisk.

With more than 50 million redeemed miles under her belt, Becky Pokora is a rewards travel expert. She's been writing about credit cards and reward travel since 2011 with articles on Forbes Advisor, ...

Merck & Co. won US approval for a novel version of its cancer drug Keytruda that’s faster to give, a key component of the marketing strategy for one of the world’s best-selling medicines as it nears ...

The acquisition will mark Pfizer’s reentry into the weight-loss market after the failure of its GLP-1 drug candidate ...

With a tool called OptiScaler, you can inject FSR 4 into any game that supports one of the three popular upscalers (FSR 2 and newer, DLSS, or XeSS). All you've got to do is unpack the OptiScaler ...

Pfizer has agreed to acquire Metsera for up to $7.3 billion, the companies said, in a deal that returns the pharma giant to the obesity and metabolic drug space from which it retreated this past ...

The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's ...

September 19, 2025: We added the new Assassin class to our Crystal of Atlan tier list. What are the best classes in the Crystal of Atlan tier list? Nuverse's action RPG splits your attention between ...

Lexicon Pharmaceuticals said on Monday it had submitted supplementary data to the U.S. Food and Drug Administration to enhance the benefit-risk profile of its experimental drug, zynquista, for ...